Activation of the unfolded protein response in Parkinson's disease
- PMID: 17254549
- DOI: 10.1016/j.bbrc.2007.01.043
Activation of the unfolded protein response in Parkinson's disease
Abstract
Parkinson's disease (PD) is, at the neuropathological level, characterized by the accumulation of misfolded proteins. The presence of misfolded proteins can trigger a cellular stress response in the endoplasmic reticulum (ER) called the Unfolded Protein Response (UPR). The UPR has been shown to be involved in cellular models for PD. In this study, we investigated UPR activation in the substantia nigra of control and PD patients. Immunoreactivity for the UPR activation markers phosphorylated pancreatic ER kinase (pPERK) and phosphorylated eukaryotic initiation factor 2alpha (peIF2alpha) is detected in neuromelanin containing dopaminergic neurons in the substantia nigra of PD cases but not in control cases. In addition, pPERK immunoreactivity is colocalized with increased alpha-synuclein immunoreactivity in dopaminergic neurons. These data show that the UPR is activated in PD and that UPR activation is closely associated with the accumulation and aggregation of alpha-synuclein.
Similar articles
-
Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease.Neurodegener Dis. 2012;10(1-4):212-5. doi: 10.1159/000334536. Epub 2012 Feb 1. Neurodegener Dis. 2012. PMID: 22302012 Review.
-
α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease.Neurobiol Dis. 2015 Apr;76:112-125. doi: 10.1016/j.nbd.2015.02.005. Epub 2015 Feb 26. Neurobiol Dis. 2015. PMID: 25725420
-
The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus.Am J Pathol. 2009 Apr;174(4):1241-51. doi: 10.2353/ajpath.2009.080814. Epub 2009 Mar 5. Am J Pathol. 2009. PMID: 19264902 Free PMC article.
-
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336
-
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.Biomolecules. 2015 Jun 5;5(2):1122-42. doi: 10.3390/biom5021122. Biomolecules. 2015. PMID: 26057626 Free PMC article. Review.
Cited by
-
Gene expression analysis of Drosophilaa Manf mutants reveals perturbations in membrane traffic and major metabolic changes.BMC Genomics. 2012 Apr 11;13:134. doi: 10.1186/1471-2164-13-134. BMC Genomics. 2012. PMID: 22494833 Free PMC article.
-
Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules.Biomolecules. 2021 Feb 11;11(2):266. doi: 10.3390/biom11020266. Biomolecules. 2021. PMID: 33670211 Free PMC article. Review.
-
Navigating the Neurobiology of Parkinson's: The Impact and Potential of α-Synuclein.Biomedicines. 2024 Sep 18;12(9):2121. doi: 10.3390/biomedicines12092121. Biomedicines. 2024. PMID: 39335634 Free PMC article. Review.
-
Promotion of the Unfolding Protein Response in Orexin/Dynorphin Neurons in Sudden Infant Death Syndrome (SIDS): Elevated pPERK and ATF4 Expression.Mol Neurobiol. 2017 Nov;54(9):7171-7185. doi: 10.1007/s12035-016-0234-3. Epub 2016 Oct 29. Mol Neurobiol. 2017. PMID: 27796753
-
Endoplasmic reticulum enrollment in Alzheimer's disease.Mol Neurobiol. 2012 Oct;46(2):522-34. doi: 10.1007/s12035-012-8301-x. Epub 2012 Jul 20. Mol Neurobiol. 2012. PMID: 22815194 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical